Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematological Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02240719
What this trial is testing

Everolimus and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Hematologic Cancer

Who this might be right for
Recurrent Adult Diffuse Large Cell LymphomaRecurrent Adult Hodgkin LymphomaRecurrent Grade 1 Follicular Lymphoma+5 more
University of California, Davis 20
Not applicableStudy completedNCT00440765
What this trial is testing

VALEO: A Post Authorization Study, Designed to Learn More About the Safety and Effectiveness of the Use of Bortezomib in the Netherlands

Who this might be right for
Multiple MyelomaHematological Neoplasms
Janssen-Cilag B.V. 331
Not applicableStudy completedNCT00005892
What this trial is testing

Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With Myelodysplastic Syndrome and Acute Leukemia Related to Fanconi's Anemia

Who this might be right for
Fanconi's AnemiaMyelodysplastic SyndromesLeukemia, Nonlymphocytic, Acute+1 more
Fairview University Medical Center
Testing effectiveness (Phase 2)Ended earlyNCT04370834
What this trial is testing

Tocilizumab for Patients With Cancer and COVID-19 Disease

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmPneumonia+3 more
National Cancer Institute (NCI) 1
Not applicableStudy completedNCT01233921
What this trial is testing

Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+86 more
Martin, Paul 6
Testing effectiveness (Phase 2)Ended earlyNCT00245128
What this trial is testing

Imatinib Mesylate in Treating Patients With Myelofibrosis

Who this might be right for
Chronic Myeloproliferative Disorders
OHSU Knight Cancer Institute 10
Not applicableStudy completedNCT04932967
What this trial is testing

Use of nMoABs for the Treatment of COVID-19 in Patients With HM.

Who this might be right for
Covid19Hematological Malignancy
Gruppo Italiano Malattie EMatologiche dell'Adulto 91
Testing effectiveness (Phase 2)Ended earlyNCT02091063
What this trial is testing

ACY-1215 for Relapsed/Refractory Lymphoid Malignancies

Who this might be right for
LymphomaLymphoid Malignancies
Jennifer Amengual 23
Early research (Phase 1)Ended earlyNCT03126864
What this trial is testing

Study of Adoptive Cellular Therapy Using Autologous T Cells Transduced With Lentivirus to Express a CD33 Specific Chimeric Antigen Receptor in Patients With Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia

Who this might be right for
Hematopoietic/Lymphoid CancerAcute Myeloid Leukemia
M.D. Anderson Cancer Center 11
Not applicableStudy completedNCT04628234
What this trial is testing

Follow-up of Actual Patient Care Site Two Months After Hospitalisation Compared With Their Expressed Choice Regarding Subsequent Care Site (RESPECT)

Who this might be right for
Hematologic MalignancyTumor, Solid
Institut de cancérologie Strasbourg Europe 53
Testing effectiveness (Phase 2)Study completedNCT00775632
What this trial is testing

Alemtuzumab and Cyclosporine for the Prevention of Graft vs Host Disease After Stem Cell Transplants

Who this might be right for
Graft Versus Host DiseaseBone Marrow Transplantation
University Health Network, Toronto 78
Post-approval studies (Phase 4)Study completedNCT03649334
What this trial is testing

Ketamine-ketorolac Versus Fentanyl- Ketorolac I.M in Children During Bone Marrow Biopsy

Who this might be right for
Hematological Malignancy (Leukemia- Lymphoma)
Mansoura University 80
Large-scale testing (Phase 3)Not Yet RecruitingNCT07636486
What this trial is testing

Luspatercept vs Epoetin in Treating Poor Erythroid Engraftment for Hematological Malignancies

Who this might be right for
LuspaterceptEpoetinPoor Erythroid Engraftment+1 more
Nanfang Hospital, Southern Medical University 90
Testing effectiveness (Phase 2)WithdrawnNCT06297629
What this trial is testing

A Phase I/II Trial to Assess the Efficacy and Toxicity of ASTX727 (Oral Decitabine/Cedazuridine) for the Treatment of Hematological Neoplasms After Allogeneic Stem Cell Transplantation

Who this might be right for
Allogeneic Stem Cell Transplantation
M.D. Anderson Cancer Center
Not applicableNot Yet RecruitingNCT07179094
What this trial is testing

The Effect of a Protective Oral Care Protocol Using Peppermint Oil Mouthwash

Who this might be right for
Hematologic NeoplasmsNauseaVomiting+1 more
Şule Güzle 72
Testing effectiveness (Phase 2)Study completedNCT00001873
What this trial is testing

The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood Cancers

Who this might be right for
Chronic Lymphocytic LeukemiaGraft vs Host DiseaseHematologic Neoplasm+2 more
National Heart, Lung, and Blood Institute (NHLBI) 102
Testing effectiveness (Phase 2)Study completedNCT02710253
What this trial is testing

Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMetastatic Malignant Solid Neoplasm
M.D. Anderson Cancer Center 214
Testing effectiveness (Phase 2)Study completedNCT00609869
What this trial is testing

Lenalidomide in Comb w/Rituximab for Pts w/CD5+/CD20+ Hem Malignancies Who Relapse/Progress After Rituximab

Who this might be right for
Lymphocytic LeukemiaMantle Cell Lymphoma
H. Lee Moffitt Cancer Center and Research Institute 29
Not applicableUnknownNCT03673631
What this trial is testing

Oxygenation Methods and Non-invasive Ventilation in Patients With Acute Respiratory Failure and a do Not Intubate Order

Who this might be right for
Acute Respiratory FailureCancerHematologic Malignancy+2 more
Poitiers University Hospital 330
Testing effectiveness (Phase 2)UnknownNCT06503094
What this trial is testing

CD19 & CD20 Bispecific CAR T Cells for Relapsed / Refractory B Cell Hematological Tumors

Who this might be right for
B-Cell Lymphoblastic Leukemia/Lymphoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 80
Next Page